GlassScriptPhysician profile
Alexander J Kim
NPI 1194082727
$3,927.61
in general payments reported to CMS, 2019-2025
11 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $614 · 2021: $437 · 2022: $293 · 2023: $554 · 2024: $705 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,583.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $1,406.59 | 2024-2025 | Evoke |
| Medtronic, INC. | $730.24 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Inceptiv |
| Boston Scientific Corporation | $670.59 | 2020-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System, Intracept |
| Spr Therapeutics, INC | $533.52 | 2020-2025 | Sprint Pns System |
| Abbott Laboratories | $134.43 | 2021 | |
| Mml US, INC. | $132.97 | 2022-2023 | Reactiv8 |
| Globus Medical, INC. | $127.70 | 2025 | Senza |
| Medtronic USA, INC. | $79.45 | 2020 | |
| Nevro Corp. | $42.10 | 2021-2023 | Senza |
| Depuy Synthes Sales INC. | $36.80 | 2024 | Orthovisc, Monovisc |
| Pacira Pharmaceuticals Incorporated | $33.22 | 2025 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.